Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients
Status
Conditions
Treatments
Details and patient eligibility
About
Glaucoma is a leading cause of blindness worldwide. Non-adherence to glaucoma medication, which may result in loss of vision, is known to be prevalent. Available information regarding adherence to prescribed medical therapy suggests that some apparent treatment failures may actually be due to non-adherence. The investigators' specific aim is to conduct a study that will examine the effect of a glaucoma educator intervention on adherence to topical glaucoma therapy. The investigators' hypothesis is that patient education and counseling delivered by a trained glaucoma educator, through both planned visits and telephone contacts, will increase adherence to topical glaucoma therapy.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Diagnosis of primary or secondary open angle glaucoma.
- Currently on monotherapy drop treatment for glaucoma.
- Age > 18 years.
- Patient has presented for care at the Rocky Mountain Lions Eye Institute Glaucoma Center.
Exclusion criteria
- Inability to independently administer eye drops due to physical disability as reported by the patient.
- Cognitive impairment that would interfere with the ability to self-administer medications as evidenced by a TICS score < 16.
- Patients who demonstrate > 80% adherence to glaucoma treatment during the 30 day run-in period.
- It is anticipated that the patient will require glaucoma surgery within the next six months.
Trial design
Primary purpose
Allocation
Interventional model
Masking
44 participants in 2 patient groups, including a placebo group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal